Bitcoin fascinates as much as it disturbs. Some see it as a hedge against inflation, while others consider it too unstable. At the heart of this debate, Semler Scientific is attracting attention by increasing its purchases of BTC. This company, active in health technology, has now invested more than $192 million in cryptocurrency. But why take such a gamble?
Massive acquisitions to emerge from the shadows
While some predict bitcoin at $500,000 by 2025, Semler Scientific did not hesitate to invest an additional $23 million in crypto.
This move pushed its total reserves to 2,321 BTC, purchased on average for less than $83,000 per coin. The company financed these purchases in part through a stock sale, demonstrating its desire to change the situation. In such a volatile market, this audacity is striking.
By investing so much, Semler Scientific saw its “bitcoin yield” climb to 99%. Behind this term hides a calculation method aimed at measuring the performance of the company in relation to its BTC holdings.
Management hopes that this figure will convince investors of the relevance of its strategy. However, this approach raises questions: is the company seeking to compensate for a lack of liquidity or to capitalize on the popularity of bitcoin?
Previously considered a “zombie company,” Semler Scientific sees bitcoin as a way to revitalize its finances.
The term “zombie” company refers to a business that is barely surviving, repaying just enough of its debts to avoid insolvency. Here, BTC is seen as a catalyst for growth. This vision breaks with the usual conservatism of the sector, showing that technological innovation can rescue activities in difficulty.
A risky bet on bitcoin, but a potential explosive return
Bitcoin remains unpredictable. Its price can skyrocket or fall suddenly in a few days.
Despite this volatility, Semler Scientific persists. Executives cite growing demand from businesses that want to protect their cash flow against inflation.
They also recall the example of MicroStrategy, a pioneer in the acquisition of BTC, whose stock market value has jumped since 2020. For Semler, speculative attraction trumps caution.
This approach is not without criticism. Many fear that a sudden crash could jeopardize the company's financial health. Critics point out that this is a high-risk bet, especially when it comes to acquiring more BTC after a significant rise. However, Semler sees blockchain as a transformative tool for the monetary system. Regulators, for their part, remain vigilant in the face of this logic of diversification.
At the same time, other companies such as Hoth Therapeutics or Rumble are following in Semler Scientific's footsteps. They are turning to bitcoin to boost their image and attract new investors. This trend shows that crypto is no longer limited to tech giants alone. For Semler, aligning with this movement reassures his partners and proves his ability to anticipate market developments despite the comparison from the CEO of JPMorgan.
Maximize your Tremplin.io experience with our 'Read to Earn' program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.
